Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Undecylenic acid 100% liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Product containing dichlorophen and undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing dibrompropamidine and undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Undecylenic acid 50 mg/mL and zinc undecylenate 200 mg/mL cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Product containing undecylenic acid and zinc undecylenate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Zinc undecylenate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Undecylenic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Undecylenic acid (substance) |
Inferred relationship |
Some |
2 |
Undecylenic acid-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only dibrompropamidine and undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only dichlorophen and undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
2 |
Undecylenic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only undecylenic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Calcium undecylenate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Propyl undecenoate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Copper undecylenate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Methyl undecenoate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
|
Undecylenic acid 50 mg/mL and zinc undecylenate 200 mg/mL cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Undecylenic acid 50 mg/mL and zinc undecylenate 200 mg/mL cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Undecylenic acid (substance) |
Inferred relationship |
Some |
1 |